A degron system targeting endogenous PD-1 inhibits the growth of tumor cells in mice.

NAR Cancer Pub Date : 2022-06-17 eCollection Date: 2022-06-01 DOI:10.1093/narcan/zcac019
Chie Naruse, Kazushi Sugihara, Tatsuhiko Miyazaki, Xuchi Pan, Fumihiro Sugiyama, Masahide Asano
{"title":"A degron system targeting endogenous PD-1 inhibits the growth of tumor cells in mice.","authors":"Chie Naruse, Kazushi Sugihara, Tatsuhiko Miyazaki, Xuchi Pan, Fumihiro Sugiyama, Masahide Asano","doi":"10.1093/narcan/zcac019","DOIUrl":null,"url":null,"abstract":"<p><p>Recently, targeted protein degradation systems have been developed using the ubiquitin-proteasome system. Here, we established Programmed cell death-1 (PD-1) knockdown mice as a model system for subjecting endogenous mouse proteins to the small molecule-assisted shutoff (SMASh) degron system. SMASh degron-tagged PD-1-mCherry in Jurkat cells and CD3<sup>+</sup> splenocytes were degraded by the NS3/4A protease inhibitors, asunaprevir (ASV) or grazoprevir (GRV). Growth of MC-38 colon adenocarcinoma cells injected in <i>Pdcd1-mCherry-SMASh</i> homozygous knock-in (KI) mice was repressed by ASV or GRV. Moreover, growth of MC-38 cells was suppressed in wild-type mice transplanted with KI bone marrow cells after GRV treatment. This is the first study to use a degron tag targeting an endogenous mouse protein <i>in vivo</i>. Our experimental system using the SMASh degron may be employed for treating diseases and characterizing the cellular functions of essential proteins.</p>","PeriodicalId":18879,"journal":{"name":"NAR Cancer","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204894/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NAR Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/narcan/zcac019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Recently, targeted protein degradation systems have been developed using the ubiquitin-proteasome system. Here, we established Programmed cell death-1 (PD-1) knockdown mice as a model system for subjecting endogenous mouse proteins to the small molecule-assisted shutoff (SMASh) degron system. SMASh degron-tagged PD-1-mCherry in Jurkat cells and CD3+ splenocytes were degraded by the NS3/4A protease inhibitors, asunaprevir (ASV) or grazoprevir (GRV). Growth of MC-38 colon adenocarcinoma cells injected in Pdcd1-mCherry-SMASh homozygous knock-in (KI) mice was repressed by ASV or GRV. Moreover, growth of MC-38 cells was suppressed in wild-type mice transplanted with KI bone marrow cells after GRV treatment. This is the first study to use a degron tag targeting an endogenous mouse protein in vivo. Our experimental system using the SMASh degron may be employed for treating diseases and characterizing the cellular functions of essential proteins.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
靶向内源性 PD-1 的 degron 系统可抑制肿瘤细胞在小鼠体内的生长。
最近,利用泛素-蛋白酶体系统开发出了靶向蛋白质降解系统。在这里,我们建立了程序性细胞死亡-1(PD-1)基因敲除小鼠作为模型系统,将小鼠内源性蛋白质置于小分子辅助关闭(SMASh)降解子系统中。Jurkat细胞和CD3+脾细胞中的SMASh degron标记PD-1-mCherry被NS3/4A蛋白酶抑制剂asunaprevir(ASV)或grazoprevir(GRV)降解。ASV或GRV抑制了注射到Pdcd1-mCherry-SMASh同基因敲入(KI)小鼠体内的MC-38结肠腺癌细胞的生长。此外,经 GRV 处理后,野生型小鼠移植 KI 骨髓细胞后,MC-38 细胞的生长也受到抑制。这是首次在体内使用以小鼠内源性蛋白质为靶标的degron标签的研究。我们使用 SMASh degron 的实验系统可用于治疗疾病和鉴定重要蛋白质的细胞功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Pan-cancer analysis of promoter activity quantitative trait loci Large-scale phenogenomic analysis of human cancers uncovers frequent alterations affecting SMC5/6 complex components in breast cancer. Inhibition of nonsense-mediated mRNA decay reduces the tumorigenicity of human fibrosarcoma cells. CDK2 regulates collapsed replication fork repair in CCNE1-amplified ovarian cancer cells via homologous recombination. Editorial: DNA repair and nucleic acid therapeutics in cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1